NXG Stock Overview
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
NexgenRx Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.29 |
| 52 Week High | CA$0.32 |
| 52 Week Low | CA$0.17 |
| Beta | 0.25 |
| 1 Month Change | 45.00% |
| 3 Month Change | 31.82% |
| 1 Year Change | -9.38% |
| 3 Year Change | -27.50% |
| 5 Year Change | 3.57% |
| Change since IPO | -17.14% |
Recent News & Updates
Optimistic Investors Push NexgenRx Inc. (CVE:NXG) Shares Up 45% But Growth Is Lacking
May 21
We Discuss Why NexgenRx Inc.'s (CVE:NXG) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
May 10Recent updates
Optimistic Investors Push NexgenRx Inc. (CVE:NXG) Shares Up 45% But Growth Is Lacking
May 21We Discuss Why NexgenRx Inc.'s (CVE:NXG) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
May 10NexgenRx Inc.'s (CVE:NXG) Price Is Out Of Tune With Revenues
Mar 14Here's Why We Think NexgenRx (CVE:NXG) Might Deserve Your Attention Today
Mar 07Is Now The Time To Put NexgenRx (CVE:NXG) On Your Watchlist?
Oct 18Does NexgenRx (CVE:NXG) Deserve A Spot On Your Watchlist?
Nov 30What NexgenRx Inc.'s (CVE:NXG) 32% Share Price Gain Is Not Telling You
Aug 24Here's Why NexgenRx Inc.'s (CVE:NXG) CEO May Have Their Pay Bumped Up
Jun 03NexgenRx Inc.'s (CVE:NXG) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 19
How Much Is NexgenRx's (CVE:NXG) CEO Getting Paid?
Dec 28Shareholder Returns
| NXG | CA Insurance | CA Market | |
|---|---|---|---|
| 7D | 31.8% | 0.8% | 1.2% |
| 1Y | -9.4% | 21.0% | 11.8% |
Return vs Industry: NXG underperformed the Canadian Insurance industry which returned 21% over the past year.
Return vs Market: NXG underperformed the Canadian Market which returned 11.8% over the past year.
Price Volatility
| NXG volatility | |
|---|---|
| NXG Average Weekly Movement | n/a |
| Insurance Industry Average Movement | 2.5% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CA Market | 17.9% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: NXG's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine NXG's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | n/a | Ron Loucks | www.nexgenrx.com |
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. It offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. The company also provides ancillary services.
NexgenRx Inc. Fundamentals Summary
| NXG fundamental statistics | |
|---|---|
| Market cap | CA$20.57m |
| Earnings (TTM) | -CA$65.95k |
| Revenue (TTM) | CA$14.68m |
1.4x
P/S Ratio-311.9x
P/E RatioIs NXG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NXG income statement (TTM) | |
|---|---|
| Revenue | CA$14.68m |
| Cost of Revenue | CA$3.20m |
| Gross Profit | CA$11.48m |
| Other Expenses | CA$11.54m |
| Earnings | -CA$65.95k |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00093 |
| Gross Margin | 78.19% |
| Net Profit Margin | -0.45% |
| Debt/Equity Ratio | 0% |
How did NXG perform over the long term?
See historical performance and comparison